Comparison of Efficacy and Safety Profile of Oral Iron Formulations in Patients with Iron Deficiency Anemia

Select Content Type
Resources
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
comparison thmbnl
Detail Image
comparison mob det img
Book Detail
Publication Date
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

Management of iron deficiency anemia involves identifying and treating the underlying cause, alongside correcting anemia through dietary improvement, oral iron supplementation, or parenteral iron therapy. Oral iron is preferred for replacing iron stores and treating mild to moderate anemia.

A study published in the International Journal of Pharmaceutical Sciences Review and Research evaluated the efficacy, safety, and cost of four oral iron preparations—ferric ammonium citrate, ferrous fumarate, ferrous sulfate, and ferrous calcium citrate—in 66 anemic patients over three months. All formulations significantly improved hemoglobin levels and anemia indices, with no significant differences in efficacy or adverse drug reactions among them. However, one formulation emerged as the most cost-effective option for patients.

Published Date